BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 33681125)

  • 1. Misinformation Drives Low Human Papillomavirus Vaccination Coverage in South African Girls Attending Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Front Public Health; 2021; 9():598625. PubMed ID: 33681125
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine Hesitancy Drives Low Human Papillomavirus Vaccination Coverage in Girls Attending Public Schools in South Africa.
    Khosa LA; Meyer JC; Motshwane FMM; Dochez C; Burnett RJ
    Front Public Health; 2022; 10():860809. PubMed ID: 35685759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus Vaccine Hesitancy Highly Evident among Caregivers of Girls Attending South African Private Schools.
    Milondzo T; Meyer JC; Dochez C; Burnett RJ
    Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability - HPV vaccine demonstration program, Cambodia - 2017.
    Garon J; Wuddhika IV; Sreenivasan N; Wannemuehler K; Vutthikol Y; Chhorvann C; Loharikar A
    Vaccine; 2019 Feb; 37(9):1202-1208. PubMed ID: 30686637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Papillomavirus Vaccination in South Africa: Programmatic Challenges and Opportunities for Integration With Other Adolescent Health Services?
    Amponsah-Dacosta E; Blose N; Nkwinika VV; Chepkurui V
    Front Public Health; 2022; 10():799984. PubMed ID: 35174123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Social media and HPV vaccination: Unsolicited public comments on a Facebook post by the Western Cape Department of Health provide insights into determinants of vaccine hesitancy in South Africa.
    Wiyeh AB; Cooper S; Jaca A; Mavundza E; Ndwandwe D; Wiysonge CS
    Vaccine; 2019 Oct; 37(43):6317-6323. PubMed ID: 31521412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
    Egbon M; Ojo T; Aliyu A; Bagudu ZS
    BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials.
    Dreyer G; Botha MH; Snyman LC; Visser C; Burden R; Laubscher N; Grond B; Richter K; Becker PJ; Harvey J; van der Merwe FH
    Int J Gynecol Cancer; 2022 May; 32(5):592-598. PubMed ID: 35078829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges.
    Msyamboza KP; Mwagomba BM; Valle M; Chiumia H; Phiri T
    BMC Public Health; 2017 Jun; 17(1):599. PubMed ID: 28651574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vaccine and cervical cancer screen (VACCS) project: acceptance of human papillomavirus vaccination in a school-based programme in two provinces of South Africa.
    Botha MH; van der Merwe FH; Snyman LC; Dreyer G
    S Afr Med J; 2015 Jan; 105(1):40-3. PubMed ID: 26046162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines.
    Vercruysse J; Chigurupati NL; Fung L; Apte G; Pierre-Joseph N; Perkins RB
    Hum Vaccin Immunother; 2016 Jun; 12(6):1606-14. PubMed ID: 26934421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV vaccination coverage and willingness to be vaccinated among 18-30 year-old students in Italy.
    Mascaro V; Pileggi C; Currà A; Bianco A; Pavia M
    Vaccine; 2019 May; 37(25):3310-3316. PubMed ID: 31064676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a national school-based Human Papillomavirus (HPV) vaccine campaign in Fiji: knowledge, vaccine acceptability and information needs of parents.
    La Vincente SF; Mielnik D; Jenkins K; Bingwor F; Volavola L; Marshall H; Druavesi P; Russell FM; Lokuge K; Mulholland EK
    BMC Public Health; 2015 Dec; 15():1257. PubMed ID: 26684658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Countering Antivax Misinformation via Social Media: Message-Testing Randomized Experiment for Human Papillomavirus Vaccination Uptake.
    Kim SJ; Schiffelbein JE; Imset I; Olson AL
    J Med Internet Res; 2022 Nov; 24(11):e37559. PubMed ID: 36422887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign.
    Delany-Moretlwe S; Kelley KF; James S; Scorgie F; Subedar H; Dlamini NR; Pillay Y; Naidoo N; Chikandiwa A; Rees H
    Glob Health Sci Pract; 2018 Oct; 6(3):425-438. PubMed ID: 30143561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Girls' explanations for being unvaccinated or under vaccinated against human papillomavirus: a content analysis of survey responses.
    Forster AS; Waller J; Bowyer HL; Marlow LA
    BMC Public Health; 2015 Dec; 15():1278. PubMed ID: 26696229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: study protocol and rationale for a pragmatic before-after design.
    Machalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J;
    BMJ Open; 2022 Feb; 12(2):e059968. PubMed ID: 35144959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Willingness and hesitancy towards the governmental free human papillomavirus vaccination among parents of eligible adolescent girls in Shenzhen, Southern China.
    Wu D; Liu P; Wang H; Wan W; Wang Y
    BMC Womens Health; 2024 Apr; 24(1):253. PubMed ID: 38654200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HPV vaccine: knowledge and attitudes among public health nurses and general practitioners in Northern Norway after introduction of the vaccine in the school-based vaccination programme.
    Nilsen K; Aasland OG; Klouman E
    Scand J Prim Health Care; 2017 Dec; 35(4):387-395. PubMed ID: 28933242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.